Difficulties And Countermeasures Of Protein Detection Technology Introduced By RG Company

"The fourteenth five year plan for national economic and social development of the People’s Republic of China(2021-2025)and the outline of long-term goals for 2035" clearly put forward to vigorously develop the strategic emerging industries represented by biomedicine,focusing on the development of gene and biotechnology,genomics application research,and realize healthy China.The goal of improving China’s life expectancy is to establish a system based on personal genetic information,combined with the application of translational medicine of proteomics and metabonomics,to conquer major diseases,develop a series of new drugs and special drugs,and comprehensively strengthen the guarantee ability of disease prevention and treatment in China.Proteomics is an important direction of Applied Research in genomics,which was proposed by Marc Wickins in 1994.It can design molecular targets for new drugs,provide markers for early diagnosis of diseases,and provide theoretical basis and solutions for elucidating and conquering diseases.One of the most important reasons is the lack of advanced biological protein detection technology and experimental platform.Facing the "short board" of science and technology and the market gap,RG company plans to introduce protein detection technology from overseas,invest in the construction of protein detection technology laboratory in China,and carry out commercial operation in China.Through the provision of testing services to enter the Chinese bioprotein testing market,to occupy the market leader position,to provide customers with products and services in line with international standards,to help RG company achieve its long-term development goals and achieve its mission.RG plans to introduce the reverse phase protein arrays(RPPA)from overseas to establish a biological laboratory in Chengdu,Sichuan,China,to carry out tumor proteomics research and provide protein detection services for Chinese scientific research institutes and hospitals.However,in order to successfully introduce RPPA technology for tumor protein detection,RG company’s preparation is not enough.At present,RG company is facing many problems,which can be summarized in three aspects: first,the lack of overall planning of RPPA technology in China;Second,how to make full use of external resources and allocate internal resources reasonably;Third,the level of corporate governance is not high,lack of talent.This paper analyzes the possibility and feasibility of introducing protein detection technology by analyzing the environment and conditions for RG company to introduce protein detection technology;Combined with the actual situation of RG company,the Countermeasures for RG company to introduce protein detection technology are studied.It is concluded that RG company needs to choose "low price" strategy,"differentiation" strategy and "open" market cooperation strategy in order to successfully introduce protein detection technology;In terms of talent strategy,it uses the strategy of building an international expert guidance team and cultivating the company’s core team;In terms of technology research and development strategy,we should carry out multi-channel technology cooperation,carry out "medical engineering" cooperation and strengthen the technology research and development to ensure the smooth implementation of the project.Finally,it also provides some safeguard measures and suggestions for the difficulties and Countermeasures of RG company’s technology introduction.This paper hopes to help RG company to expand its bioprotein detection business in China,make clear the development strategy and realize the strategic goal of "becoming the top biotechnology service provider in China" by studying the difficulties and Countermeasures Faced by RG company in introducing protein detection technology.